Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Wondering what do you need to start investing? Discover the essential tools and knowledge required to kickstart your investment journey.
19,065 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
As dividend yields tempt investors, the real question is how much your dividend income actually lands in your pocket ...
Massive passive flows into the Russell 2000 through IWM are lifting small caps, even as investors await the next Fed ...
Two retirees with the same income saw different Medicare costs in 2026 when one filed a life-changing-event form. The...
Eli Lilly shares surged to fresh highs, underpinned by upbeat analyst notes and strong pipeline momentum. This guide ...
A CFO selling NuScale stock can spark questions about the company’s outlook. This guide breaks down what the move mig...
Gas prices could push toward $4 a gallon again as a new IRS rule expands the gas expense deduction. The change target...
As AI spending shifts from hype to heavy borrowing, Goldman Sachs warns AI's debt tsunami may tighten credit markets....
Chemed has faced a challenging year, even as its business lines stay essential. This article breaks down the drivers ...
Is Pfizer stock undervalued in the crowded healthcare space? This deep dive weighs cash flow, dividends, pipeline pot...
Wasatch Advisors dumped a large Trex stake, triggering a sharp move in Trex shares. This piece explains what happened...
Explore ibotta (ibta) 2025 earnings projections, including revenue drivers, user growth, and profitability timelines....